The function of these implants from the company of billionaire Elon Musk will consist of “reading” brain activity in order to be able to transmit orders that help restore some severely damaged brain functions.
The Neurolink company, owned by billionaire Elon Musk, will begin human studies of its brain implants, following approval from the Food and Drug Administration (FDA). The function of these will be to “read” brain activity in order to transmit orders that help restore some severely damaged brain functions.
Musk indicated in early December that the company was ready to carry out this type of implant. Since then, the FDA has been concerned about possible damage that these implants could cause, but has finally decided to approve the project.
“It represents an important first step that will one day allow our technology to help many people,” Neurolink said after the approval.
Until today, the brain implants that have been used were unidirectional; that is, from the brain to the outside. Instead, the implants of Musk’s company will transmit the information in a bidirectional way. Therefore, they will also be able to receive a direct signal to the brain.
The function of these will be to “read” brain activity in order to be able to transmit orders that restore damaged brain functions, which result in serious damage to communication capacity.
Source: Eitb
With a background in journalism and a passion for technology, I am an experienced writer and editor. As an author at 24 News Reporter, I specialize in writing about the latest news and developments within the tech industry. My work has been featured on various publications including Wired Magazine and Engadget.